#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired haemophilia Myeloid leukaemia Heart disease congenital Acute myeloid leukaemia recurrent Brain injury Wolfram syndrome Loeys-Dietz syndrome Cutaneous T-cell lymphoma stage I Autoinflammation with infantile enterocolitis Infertility male Arrhythmia Fatty acid oxidation disorder Leukocyte adhesion deficiency type I Usher's syndrome Diabetes insipidus More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome – Diagnostics Shprintzen-Goldberg syndrome – Treatment Thrombotic thrombocytopenic purpura – Basic Information Amyotrophic lateral sclerosis – Basic Information Progressive multifocal leukoencephalopathy – Diagnostics Cytokine release syndrome – Basic Information Encephalitis autoimmune Haemophilia – Basic Information Chronic granulomatous disease – Life with Disease VEXAS syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Camizestrant Ubiquinol Anastrozole Dexrazoxane Tasimelteon Sonelokimab Dulaglutide Sulfonamides, Urea Derivatives Selpercatinib Dasatinib Glutathione Bemcentinib Sarilumab Phenol, Liquefied Gd2Il18Cart Daratumumab Filgotinib Brodalumab [68GA]GA-NOTA-AE105 Ampicillin More therapies…

    Learn about Your Condition

    Lyme disease Post-traumatic stress disorder Pre-eclampsia Oral lichen planus Bacteraemia Angiosarcoma recurrent Breast cancer stage IV Renal injury Ovarian cancer recurrent Tetanus Haemorrhagic stroke Pseudomonas infection Carcinoid tumour pulmonary Eosinophilic oesophagitis Habitual abortion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Fracture infection

  • Study on Clindamycin and Rifampicin for Treating Infections in Patients with Obesity, Fracture-Related Infections, Hidradenitis Suppurativa, or Prosthetic Joint Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fracture infection
    • Medical device site joint infection
    Investigated Drugs:
    • Clindamycin Hydrochloride
    • Rifampicin
    Belgium

  • Supplementary Oxygen Therapy for Patients with Fracture-Related Infection After Limb Debridement and Reconstruction Surgery: A Pilot Randomized Trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Fracture infection
    Investigated Drugs:
    • Oxygen
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!